Hartford Financial Management’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-533
| Closed | -$2K | – | 381 |
|
2023
Q1 | $2K | Hold |
533
| – | – | ﹤0.01% | 348 |
|
2022
Q4 | $1.65K | Hold |
533
| – | – | ﹤0.01% | 353 |
|
2022
Q3 | $2K | Hold |
533
| – | – | ﹤0.01% | 361 |
|
2022
Q2 | $14K | Hold |
533
| – | – | ﹤0.01% | 263 |
|
2022
Q1 | $20K | Hold |
533
| – | – | ﹤0.01% | 256 |
|
2021
Q4 | $31K | Hold |
533
| – | – | 0.01% | 238 |
|
2021
Q3 | $44K | Hold |
533
| – | – | 0.01% | 216 |
|
2021
Q2 | $50K | Hold |
533
| – | – | 0.01% | 207 |
|
2021
Q1 | $34K | Hold |
533
| – | – | 0.01% | 222 |
|
2020
Q4 | $31K | Hold |
533
| – | – | 0.01% | 226 |
|
2020
Q3 | $11K | Hold |
533
| – | – | ﹤0.01% | 259 |
|
2020
Q2 | $8K | Hold |
533
| – | – | ﹤0.01% | 275 |
|
2020
Q1 | $7K | Hold |
533
| – | – | ﹤0.01% | 282 |
|
2019
Q4 | $11K | Hold |
533
| – | – | ﹤0.01% | 289 |
|
2019
Q3 | $17K | Hold |
533
| – | – | 0.01% | 272 |
|
2019
Q2 | $12K | Buy |
533
+66
| +14% | +$1.49K | ﹤0.01% | 289 |
|
2019
Q1 | $18K | Buy |
+467
| New | +$18K | 0.01% | 270 |
|
2018
Q1 | – | Sell |
-43
| Closed | -$1K | – | 363 |
|
2017
Q4 | $1K | Hold |
43
| – | – | ﹤0.01% | 338 |
|
2017
Q3 | $2K | Hold |
43
| – | – | ﹤0.01% | 372 |
|
2017
Q2 | $2K | Hold |
43
| – | – | ﹤0.01% | 353 |
|
2017
Q1 | $2K | Hold |
43
| – | – | ﹤0.01% | 332 |
|
2016
Q4 | $5K | Hold |
43
| – | – | ﹤0.01% | 280 |
|
2016
Q3 | $5K | Buy |
43
+6
| +16% | +$698 | ﹤0.01% | 275 |
|
2016
Q2 | $4K | Buy |
+37
| New | +$4K | ﹤0.01% | 260 |
|